Company intelligence / Profile preview

Applied Pharmaceutical Science, Inc.

San Diego, United Statesapspharm.com ↗

Ownership: Private
Employees: ~49
Development stage: Other

Overview

APS’s lead asset APS03118 is a next-generation selective RET inhibitor currently in Phase I/II clinical trials targeting patients with advanced solid tumors harboring RET mutations or fusions. Preclinical data show high selectivity and potent activity against various resistant mutations. Early clinical results indicate promising efficacy and safety profiles in heavily pretreated populations.

Therapeutic areas: Oncology
Modalities: Small molecule drugsChemical drugsOligonucleotides (in pipeline)Biological products (in pipeline)
Industry: Biotech

Drug pipeline

4 assets

APS03118

3 more assets in the full pipeline.

Request access →

Partnerships

APS actively seeks global partnerships with biomedical research institutions and companies at all stages of drug development through co-development, license-out/in models.

Beyond the preview

Go deeper on Applied Pharmaceutical Science, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Applied Pharmaceutical Science, Inc..

Explore the full profile